Emsella for Reducing tSUI After HOLEP

ConditionsBenign Prostatic Hyperplasia Enlarged Prostate With Lower Urinary Tract Symptoms Enlarged Prostate (BPH)

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexMale

Age50-80

SponsorNorthwestern University

About this trial

This study aims to investigate the effectiveness of the Emsella chair treatments at different timepoints. Before and after the holmium laser enucleation of the prostate (HoLEP).

Eligibility criteria

Qualifiers

Prostate sizing 80-150g

Ability to independently transfer and tolerate all 30min Emsella treatments (e.g. not wheelchair bound, no mobility issues)

Baseline M-ISI scores <4

Same-day catheter removal and discharge

Disqualifiers

Catheter dependence

Previous BPH procedure

Previous pelvic surgeries

Pre-existing pelvic floor dysfunction

Trial design

Treatments tested in this trial

Emsella chair

Treatment groups

30 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Northwestern University

Lead sponsor

Source ClinicalTrials.gov